New York Presbyterian Columbia Irving Comprehensive Cancer Center — New York, New York

New York Presbyterian Columbia Irving Comprehensive Cancer Center is a clinical research site located in New York, New York, United States 10032.

Crixeo Health Trust Score: 54/100 (POOR). This profile has not yet been claimed by the site owner.

New York Presbyterian Columbia Irving Comprehensive Cancer Center has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Breast Neoplasms, Breast Diseases.

Sponsors: Icahn School of Medicine at Mount Sinai.

Sponsor Feasibility Report

Trust Score: 54/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for New York Presbyterian Columbia Irving Comprehensive Cancer Center?

New York Presbyterian Columbia Irving Comprehensive Cancer Center has a Crixeo Trust Score of 54/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has New York Presbyterian Columbia Irving Comprehensive Cancer Center conducted?

New York Presbyterian Columbia Irving Comprehensive Cancer Center has 1 clinical trials on record, with 1 currently active. Their work covers Breast Neoplasms, Breast Diseases.

Is New York Presbyterian Columbia Irving Comprehensive Cancer Center accredited by Crixeo Health?

New York Presbyterian Columbia Irving Comprehensive Cancer Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about New York Presbyterian Columbia Irving Comprehensive Cancer Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.